Oncgnostics GmbH - Product Pipeline Analysis, 2017 Update

  • ID: 4267291
  • Company Profile
  • 24 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • BioNTech AG
  • biosyn Arzneimittel GmbH
  • BIOTECON Diagnostics GmbH
  • MORE
Summary:

Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company that specializes in the development of in-vitro diagnostic tests for the therapeutics area of cancer. The company’s pipeline offers GynTect technology, a system based on the detection of epigenetic biomarkers, mainly in the methylation of specific DNA regions. Its GynTect allows a fast and reliable detection of cervical precancerous lesions and cancer. The company’s pipeline focuses on applications in the fields that include ovarian cancer and head-and-neck tumors. It also specializes in the IVD test development field at, after test validation and initial preclinical trials, and others. Oncgnostics is headquartered in Jena, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Oncgnostics GmbH
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy::

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • BioNTech AG
  • biosyn Arzneimittel GmbH
  • BIOTECON Diagnostics GmbH
  • MORE
List of Tables
List of Figures
Oncgnostics GmbH Company Overview
Oncgnostics GmbH Company Snapshot
Oncgnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview
Oncgnostics GmbH - Pipeline Analysis Overview
Oncgnostics GmbH - Key Facts
Oncgnostics GmbH - Major Products and Services
Oncgnostics GmbH Pipeline Products by Development Stage
Oncgnostics GmbH Pipeline Products Overview
GynTect
GynTect Product Overview
GynTect 2.0
GynTect 2.0 Product Overview
Oncgnostics Diagnostic Test - Head & Neck Cancer
Oncgnostics Diagnostic Test - Head & Neck Cancer Product Overview
Oncgnostics Diagnostic Test - Ovarian Cancer
Oncgnostics Diagnostic Test - Ovarian Cancer Product Overview
Oncgnostics GmbH - Key Competitors
Oncgnostics GmbH - Key Employees
Oncgnostics GmbH - Locations And Subsidiaries
Head Office
Recent Developments
Oncgnostics GmbH, Recent Developments
Sep 20, 2016: Early Detection of Ervical cancer: “ GynTect 2.0“- Wider Range of Application by Using a Greater Variety of Patient Samples
Apr 28, 2016: Oncgnostics cooperates with SAYRE Therapeutics in India
Jan 20, 2016: Safe Diagnostics for Women Tested HPV-Positive
Sep 18, 2015: Fast and Reliable Results in Cancer Diagnostics: Biotech Startup Oncgnostics Receives CE Mark for Cervical Cancer Test GynTect
Nov 25, 2014: Oncgnostics Received Award At The Thuringian Innovation Prize 2014

Appendix
Methodology

About
Contact Us
Disclaimer

List of Tables:
Oncgnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview
Oncgnostics GmbH Pipeline Products by Equipment Type
Oncgnostics GmbH Pipeline Products by Indication
Oncgnostics GmbH, Key Facts
Oncgnostics GmbH, Major Products and Services
Oncgnostics GmbH Number of Pipeline Products by Development Stage
Oncgnostics GmbH Pipeline Products Summary by Development Stage
GynTect - Product Status
GynTect - Product Description
GynTect 2.0 - Product Status
GynTect 2.0 - Product Description
Oncgnostics Diagnostic Test - Head & Neck Cancer - Product Status
Oncgnostics Diagnostic Test - Head & Neck Cancer - Product Description
Oncgnostics Diagnostic Test - Ovarian Cancer - Product Status
Oncgnostics Diagnostic Test - Ovarian Cancer - Product Description
Oncgnostics GmbH, Key Employees
Glossary

List of Figures:
Oncgnostics GmbH Pipeline Products by Equipment Type
Oncgnostics GmbH Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • BIOTECON Diagnostics GmbH
  • biosyn Arzneimittel GmbH
  • BioNTech AG
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll